Evidence for Involvement of Calcitonin Gene-Related Peptide in Nitroglycerin Response and Association With Mitochondrial Aldehyde Dehydrogenase-2 (ALDH2) Glu504Lys Polymorphism

Journal of the American College of Cardiology

Volumn 52, Issue 11, 2008, Pages 953-960

  Guo, Ren ^a   Chen, Xiao Ping ^a   Guo, Xin ^a   Chen, Lei ^a   Li, Dai ^a   Peng, Jun ^a   Li, Yuan Jian ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

calcitonin gene related peptide; genetic polymorphism; mitochondrial aldehyde dehydrogenase 2; nitroglycerin; peripheral blood mononuclear cells

Indexed keywords

ALDEHYDE DEHYDROGENASE ISOENZYME 2; CALCITONIN GENE RELATED PEPTIDE; CHLORAL HYDRATE; GLUTAMIC ACID; GLYCERYL TRINITRATE; LYSINE; MESSENGER RNA; MITOCHONDRIAL ENZYME;

ADULT; ARTICLE; CARDIOVASCULAR EFFECT; CHINESE; CONTROLLED STUDY; DRUG EFFICACY; EXPERIMENTAL MODEL; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HEART RATE; HOMOZYGOTE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHARMACOGENETICS; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TREATMENT RESPONSE; VOLUNTEER;

ADULT; ALDEHYDE DEHYDROGENASE; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; CALCITONIN GENE-RELATED PEPTIDE; CELLS, CULTURED; GENOTYPE; HEART RATE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; NITROGLYCERIN; POLYMORPHISM, GENETIC; RNA, MESSENGER; UP-REGULATION;

EID: 50349085221     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.05.049     Document Type: Article

References (30)

1. Ignarro L.J., Cirino G., Casini A., and Napoli C. Nitric oxide as a signaling molecule in the vascular system: an overview. J Cardiovasc Pharmacol 34 (1999) 879-886
2. Brain S.D., Williams T.J., Tippins J.R., Morris H.R., and MacIntyre I. Calcitonin gene-related peptide is a potent vasodilator. Nature 313 (1985) 54-56
3. Franco-Cereceda A., Henke H., Lundberg J.M., Petermann J.B., Hökfelt T., and Fischer J.A. Calcitonin gene-related peptide (CGRP) in capsaicin-sensitive substance P-immunoreactive sensory neurons in animals and man: distribution and release by capsaicin. Peptides 8 (1987) 399-410
4. Zaidi M., Bevis P.J., Girgis S.I., Lynch C., Stevenson J.C., and MacIntyre I. Circulating CGRP comes from the perivascular nerves. Eur J Pharmacol 117 (1985) 283-284
5. Pardutz A., Multon S., Malgrange B., Parducz A., Vecsei L., and Schoenen J. Effect of systemic nitroglycerin on CGRP and 5-HT afferents to rat caudal spinal trigeminal nucleus and its modulation by estrogen. Eur J Neurosci 15 (2002) 1803-1809
6. Ghatta S., and O'Rourke S.T. Nitroglycerin-induced release of calcitonin gene-related peptide from sensory nerves attenuates the development of nitrate tolerance. J Cardiovasc Pharmacol 47 (2006) 175-181
7. Booth B.P., Tabrizi-Fard M.A., and Fung H. Calcitonin gene-related peptide-dependent vascular relaxation of rat aorta. An additional mechanism for nitroglycerin. Biochem Pharmacol 59 (2000) 1603-1609
8. Nie S.D., Hu C.P., Chen Y.R., Wang S., Deng H.W., and Li Y.J. Reversal of tolerance to nitroglycerin with vinpocetine: a role of calcitonin gene-related peptide. Int J Cardiol 125 (2008) 436-438
9. Zhou Z.H., Jiang J.L., Peng J., Deng H.W., and Li Y.J. Reversal of tolerance to nitroglycerin with N-acetylcysteine or captopril: a role of calcitonin gene-related peptide. Eur J Pharmacol 493 (2002) 129-134
10. Zhou Z.H., Deng H.W., and Li Y.J. The depressor effect of nitroglycerin is mediated by calcitonin gene-related peptide. Life Sci 69 (2001) 1313-1320
11. Juhasz G., Zsombok T., Modos E.A., et al. NO-induced migraine attack: strong increase in plasma calcitonin gene-related peptide (CGRP) concentration and negative correlation with platelet serotonin release. Pain 106 (2003) 461-470
12. Juhasz G., Zsombok T., Jakab B., Nemeth J., Szolcsanyi J., and Bagdy G. Sumatriptan causes parallel decrease in plasma calcitonin gene-related peptide (CGRP) concentration and migraine headache during nitroglycerin induced migraine attack. Cephalalgia 25 (2005) 179-183
13. Mitchell J.A., Williams F.M., Williams T.J., and Larkin S.W. Role of nitric oxide in the dilator actions of capsaicin-sensitive nerves in the rabbit coronary circulation. Neuropeptides 31 (1997) 333-338
14. Mackenzie I.S., Maki-Petaja K.M., McEniery C.M., et al. Aldehyde dehydrogenase 2 plays a role in the bioactivation of nitroglycerin in humans. Arterioscler Thromb Vasc Biol 25 (2005) 1891-1895
15. Chen Z., Foster M.W., Zhang J., et al. An essential role for mitochondrial aldehyde dehydrogenase in nitroglycerin bioactivation. Proc Natl Acad Sci U S A 102 (2005) 12159-12164
16. Chen Z., and Stamler J.S. Bioactivation of nitroglycerin by the mitochondrial aldehyde dehydrogenase. Trends Cardiovasc Med 16 (2006) 259-265
17. Wang R.S., Nakajima T., Kawamoto T., and Honma T. Effects of aldehyde dehydrogenase-2 genetic polymorphisms on metabolism of structurally different aldehydes in human liver. Drug Metab Dispos 30 (2002) 69-73
18. Li Y., Zhang D., Jin W., et al. Mitochondrial aldehyde dehydrogenase-2 (ALDH2) Glu504Lys polymorphism contributes to the variation in efficacy of sublingual nitroglycerin. J Clin Invest 116 (2006) 506-511
19. Linscheid P., Seboek D., Schaer D.J., Zulewski H., Keller U., and Müller B. Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and by macrophage-activated adipocytes. Crit Care Med 32 (2004) 1715-1721
20. Ho T.W., Mannix L.K., Fan X., et al. Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine. Neurology 70 (2008) 1304-1312
21. Edvinsson L. Clinical data on the CGRP antagonist BIBN4096BS for treatment of migraine attacks. CNS Drug Rev 11 (2005) 69-76
22. Kunz T.H., Scott M., Ittner L.M., Fischer J.A., Born W., and Vogel J. Calcitonin gene-related peptide-evoked sustained tachycardia in calcitonin receptor-like receptor transgenic mice is mediated by sympathetic activity. Am J Physiol Heart Circ Physiol 293 (2007) H2155-H2160
23. Bellamy J., Bowen E.J., Russo A.F., and Durham P.L. Nitric oxide regulation of calcitonin gene-related peptide gene expression in rat trigeminal ganglia neurons. Eur J Neurosci 23 (2006) 2057-2066
24. Zhang H., Chen Y.G., Xu F., Xue L., Jiang C.X., and Zhang Y. The relationship between aldehyde dehydrogenase-2 gene polymorphisms and efficacy of nitroglycerin. Zhonghua Nei Ke Za Zhi 46 (2007) 629-632
25. Martin D.D., Tong J.S., and Parker J.D. Platelet cyclic GMP responses to nitroglycerin. Cardiovasc Drugs Ther 14 (2000) 419-425
26. Esplugues J.V., Rocha M., Nuñez C., et al. Complex I dysfunction and tolerance to nitroglycerin: an approach based on mitochondrial-targeted antioxidants. Circ Res 99 (2006) 1067-1075
27. Sydow K., Daiber A., Oelze M., et al. Central role of mitochondrial aldehyde dehydrogenase and reactive oxygen species in nitroglycerin tolerance and cross-tolerance. J Clin Invest 113 (2004) 482-489
28. Szöcs K., Lassègue B., Wenzel P., et al. Increased superoxide production in nitrate tolerance is associated with NAD(P)H oxidase and aldehyde dehydrogenase 2 downregulation. J Mol Cell Cardiol 42 (2007) 1111-1118
29. Hink U., Daiber A., Kayhan N., et al. Oxidative inhibition of the mitochondrial aldehyde dehydrogenase promotes nitroglycerin tolerance in human blood vessels. J Am Coll Cardiol 50 (2007) 2226-2232
30. Chen Y.R., Nie S.D., Shan W., et al. Decrease in endogenous CGRP release in nitroglycerin tolerance: role of ALDH-2. Eur J Pharmacol 571 (2007) 44-50